Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
36.55
+0.33 (0.91%)
At close: Apr 24, 2026, 4:00 PM EDT
36.25
-0.30 (-0.82%)
After-hours: Apr 24, 2026, 7:36 PM EDT
Bruker Revenue
In the year 2025, Bruker had annual revenue of $3.44B with 2.08% growth. Bruker had revenue of $977.20M in the quarter ending December 31, 2025, a decrease of -0.24%.
Revenue (ttm)
$3.44B
Revenue Growth
+2.08%
P/S Ratio
1.62
Revenue / Employee
$310,014
Employees
11,085
Market Cap
5.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.44B | 70.10M | 2.08% |
| Dec 31, 2024 | 3.37B | 401.90M | 13.56% |
| Dec 31, 2023 | 2.96B | 433.80M | 17.14% |
| Dec 31, 2022 | 2.53B | 112.80M | 4.67% |
| Dec 31, 2021 | 2.42B | 430.40M | 21.66% |
| Dec 31, 2020 | 1.99B | -85.10M | -4.11% |
| Dec 31, 2019 | 2.07B | 177.00M | 9.34% |
| Dec 31, 2018 | 1.90B | 129.70M | 7.34% |
| Dec 31, 2017 | 1.77B | 154.60M | 9.59% |
| Dec 31, 2016 | 1.61B | -12.50M | -0.77% |
| Dec 31, 2015 | 1.62B | -185.10M | -10.23% |
| Dec 31, 2014 | 1.81B | -30.50M | -1.66% |
| Dec 31, 2013 | 1.84B | 48.00M | 2.68% |
| Dec 31, 2012 | 1.79B | 139.70M | 8.46% |
| Dec 31, 2011 | 1.65B | 346.80M | 26.58% |
| Dec 31, 2010 | 1.30B | 190.40M | 17.08% |
| Dec 31, 2009 | 1.11B | 7.40M | 0.67% |
| Dec 31, 2008 | 1.11B | 74.70M | 7.24% |
| Dec 31, 2007 | 1.03B | 181.00M | 21.26% |
| Dec 31, 2006 | 851.40M | 479.15M | 128.72% |
| Dec 31, 2005 | 372.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Globus Medical | 2.94B |
| Bio-Rad Laboratories | 2.58B |
| Bio-Rad Laboratories | 2.58B |
| Integer Holdings | 1.85B |
| Masimo | 1.53B |
| Penumbra | 1.40B |
| LivaNova | 1.39B |
| Haemonetics | 1.32B |
BRKR News
- 1 day ago - Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Business Wire
- 8 days ago - Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - Business Wire
- 8 days ago - Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 - Business Wire
- 8 days ago - Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management - Business Wire
- 12 days ago - Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 - Business Wire
- 18 days ago - Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research - Business Wire
- 24 days ago - Bruker Announces Appointment of Thierry Bernard to its Board of Directors - Business Wire
- 2 months ago - Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR - Business Wire